# First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts

> **NCT02106260** · PHASE1,PHASE2 · COMPLETED · sponsor: **Maruho Co., Ltd.** · enrollment: 12 (actual)

## Conditions studied

- Cutaneous Warts

## Interventions

- **DRUG:** CLS003

## Key facts

- **NCT ID:** NCT02106260
- **Lead sponsor:** Maruho Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-04
- **Final completion:** —
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02106260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02106260, "First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02106260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*